Trials / Conditions / Monocarboxylate Transporter 8 Deficiency
Monocarboxylate Transporter 8 Deficiency
3 registered clinical trials studyying Monocarboxylate Transporter 8 Deficiency.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Withdrawal of Tiratricol Treatment in Males With Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency) NCT05579327 | Rare Thyroid Therapeutics International AB | Phase 3 |
| Unknown | Glycerol-Phenylbutyrate Treatment in Children With MCT Mutation (Allan-Herndon- Dudley Syndrome) NCT05019417 | Kaplan Medical Center | Phase 2 / Phase 3 |
| Available | Expanded Access Program for Tiratricol in Patients With Monocarboxylate Transporter 8 Deficiency NCT05911399 | Rare Thyroid Therapeutics International AB | — |